Home › Funds › Remedium Capital Partners, LLC › ANIX
Remedium Capital Partners, LLC position in ANIX
ANIXA BIOSCIENCES · Health Care
Remedium Capital Partners, LLC reported holding 518,500 shares of ANIX (ANIXA BIOSCIENCES) in its Q3 2026 13F filing — a position valued at US$16.6M, representing 6.06% of its reported portfolio and ranking #5 among its reported holdings. Remedium Capital Partners, LLC first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Remedium Capital Partners, LLC's ANIX position evolved
Remedium Capital Partners, LLC first disclosed a stake in ANIX in Q3 2026 at 518,500 shares (US$16.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 518.50K | $16.59M | New |
About ANIX and 13F data
ANIX (ANIXA BIOSCIENCES) is a Health Care company. 36 other funds we track also report a position in ANIX — the largest reported positions include Sanofi (US$63.8M), Vivo Capital, LLC (US$28.1M), Kalehua Capital Management LLC (US$14.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANIX
- Sanofi 1.99M sh · $63.81M · Q3 2026
- Vivo Capital, LLC 877.02K sh · $28.06M · Q3 2026
- Kalehua Capital Management LLC 442.65K sh · $14.16M · Q3 2026
- NEXTBio Capital Management LP 175.40K sh · $5.61M · Q3 2026
More on Remedium Capital Partners, LLC
FAQ
How long has Remedium Capital Partners, LLC held ANIX?
Remedium Capital Partners, LLC has disclosed ANIX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Remedium Capital Partners, LLC's current position in ANIX?
As of Q3 2026, Remedium Capital Partners, LLC holds 518.50K shares of ANIX (ANIXA BIOSCIENCES), valued at $16.59M, representing 6.06% of its reported portfolio and ranking #5.
Has Remedium Capital Partners, LLC been buying or selling ANIX?
In the latest 13F filing (Q3 2026), Remedium Capital Partners, LLC newly opened its position in ANIX.
Which other funds hold ANIX?
Other major institutional holders of ANIX include Sanofi, Vivo Capital, LLC, Kalehua Capital Management LLC, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.